|
14 Mar 2023 |
|
Latest News |
|
|
|
Munro benefits from controversial Ozempic use | Off-label usage of a controversial diabetes drug has been beneficial for Munro Partners’ Global Growth fund with the firm expecting this type of medication to become the next “blockbuster drug”. |
|
|
|
|
|
Features |
The state of financial wellbeing in Australia | Amid inflation, interest hikes, and changes to superannuation, financial capability remains at the forefront of conversations, though many are concerned about Australians’ ability to manage their money. |
|
|